No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs113517575 |
chr14:46357608-46357609 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs562550766 |
chr14:46357627-46357628 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs10142032 |
chr14:46357634-46357635 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs180884203 |
chr14:46357670-46357671 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs543212284 |
chr14:46357681-46357682 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs561592209 |
chr14:46357686-46357687 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs2768516 |
chr14:46357687-46357688 |
Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs546979467 |
chr14:46357688-46357689 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs547470059 |
chr14:46357693-46357694 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs561663786 |
chr14:46357706-46357707 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs393645 |
chr14:46357712-46357713 |
Active TSS Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs77536935 |
chr14:46357719-46357720 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs568992514 |
chr14:46357740-46357741 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs393678 |
chr14:46357747-46357748 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs192513622 |
chr14:46357751-46357752 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs201145308 |
chr14:46357753-46357754 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs376217815 |
chr14:46357754-46357755 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs547952959 |
chr14:46357774-46357775 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs183795495 |
chr14:46357787-46357788 |
Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs201652586 |
chr14:46357808-46357809 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs566439462 |
chr14:46357851-46357852 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs146932058 |
chr14:46357854-46357855 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs558813462 |
chr14:46357869-46357870 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs576792858 |
chr14:46357930-46357931 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs537835406 |
chr14:46357937-46357938 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs556312129 |
chr14:46357958-46357959 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs574560482 |
chr14:46357960-46357961 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs71517479 |
chr14:46357977-46357978 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs561425275 |
chr14:46357978-46357979 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs573373123 |
chr14:46357997-46357998 |
Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs551463943 |
chr14:46358013-46358014 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs540616252 |
chr14:46358014-46358015 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs4333557 |
chr14:46358015-46358016 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs4507734 |
chr14:46358023-46358024 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs112086196 |
chr14:46358042-46358043 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs79246215 |
chr14:46358049-46358050 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs76469102 |
chr14:46358050-46358051 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs75342822 |
chr14:46358054-46358055 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs80246264 |
chr14:46358058-46358059 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs76831952 |
chr14:46358059-46358060 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs533832003 |
chr14:46358061-46358062 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs71626862 |
chr14:46358062-46358063 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs74741492 |
chr14:46358064-46358065 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs74508066 |
chr14:46358068-46358069 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs79379947 |
chr14:46358078-46358079 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs76453467 |
chr14:46358080-46358081 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs550526370 |
chr14:46358082-46358083 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs78281017 |
chr14:46358083-46358084 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs74533924 |
chr14:46358084-46358085 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs79614853 |
chr14:46358085-46358086 |
Active TSS Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|